RESULTS	The eradication rates were 75.6 and 83.8 % with moxifloxacin triple therapy , and 54.5 and 72.7 % with quadruple therapy by intention-to-treat ( p = .042 ) and per-protocol analyses ( p = .260 ) , respectively .\